Skip to main content

Table 5 Adverse reactions associated with BTX-A treatment

From: Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study

 

Single dose

Repeated dose

P

Subjects, n

44

37

 

Patients experiencing side effects, n (%)

7 (15.9)

7 (18.9)

0.774

Time before side effects, d

2.22 ± 7.2042

2.405 ± 5.7805

0.904

Duration of side effects, d

7.068 ± 20.9411

8.703 ± 22.0893

0.734

  1. d day